logo
Plus   Neg
Share
Email

ITV 9-month Total Revenue Down 1%; Says On Track To Deliver FY View

ITV Plc (ITV.L) said Tuesday that total revenue for the nine months ended 30 September 2019 declined 1 percent from the year-ago period and said it is on track to deliver its full-year guidance.

For the nine months ended 30 September 2019, ITV's total revenue declined 1 percent to 2.58 billion pounds from 2.62 billion pounds in the year-ago period. Total external revenue declined 2 percent from last year to 2.21 billion pounds.

Broadcast & Online revenues decreased 3 percent to 1.46 billion pounds, while ITV Studios revenues rose 1 percent to 1.116 billion pounds with organic growth flat, at constant currency.

Looking ahead, ITV said it is confident in delivering its 2019 full-year guidance. The company added it is confident ITV Studios will deliver revenue growth of at least 5 percent, at a 14 percent to 16 percent margin.

ITV added that its cost program is on track to deliver 20 million pounds of savings this year, and 55 million pounds to 60 million pounds over the four years to 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
NBCUniversal unveiled Peacock, a free premium ad-supported streaming service with subscription tiers offering more than 600 movies and 400 series. Peacock will be available on April 15 for Comcast's Xfinity X1 and Flex customers and on July 15 for the rest of the country. NBC is offering Peacock... The number of Amazon Prime members in the U.S. is growing slowly, but steadily, a recent study has shown. According to the survey by the Consumer Intelligence Research Partners, LLC or CIRP, the number of Amazon Prime members in the U.S. is estimated to have risen to 112 million in December 2019 from just over 100 million in the same period of the prior year. Medical device manufacturer Cardinal Health will soon recall certain Level 3 surgical gowns or PreSource procedural packs that contain these gowns following warning that they may not be sterile, the U.S. Food and Drug Administration said in a statement. The health regulator said it is working with the company to find out the specific product lots that are impacted.
RELATED NEWS
Follow RTT
>